Core Viewpoint - The Shanghai Stock Exchange is set to review the IPO application of Suzhou Fengbei Biotechnology Co., Ltd. on August 7, 2025, marking a significant step for the company in the waste resource utilization sector [1] Company Summary - Suzhou Fengbei Biotechnology is a high-tech enterprise focused on the comprehensive utilization of waste resources, specifically converting waste oils into resource products [1] - The company’s IPO application was accepted on June 8, 2023, and it entered the inquiry phase on July 5, 2023 [1] - In the latest meeting materials, Fengbei Biotechnology has adjusted its fundraising projects, canceling the previously planned "supplementary working capital project," which was set to raise 250 million yuan [1] - Following the cancellation of the working capital project, the total amount intended to be raised in the IPO has been reduced to 750 million yuan, which will be allocated to several new projects, including the construction of a 300,000-ton/year oleic acid methyl ester plant, a 10,000-ton industrial mixed oil facility, a 50,000-ton agricultural microbial agent project, a 10,000-ton compound microbial fertilizer project, and the production of 50,000 tons of biodiesel and 8,200 tons of glycerol as by-products [1]
IPO上会在即!丰倍生物取消2.5亿元补流项目
Bei Jing Shang Bao·2025-08-03 03:39